Issue 40 Februay 2012

Dear Friends,

In this edition of GEMS we are proudly presenting before you, two of our research papers presented at the largest and most prestigious Diabetes Technology International Conference, Advanced Technologies and Treatments for Diabetes (ATTD), Barcelona, Spain, February 8-11, 2012.

As usual, we have included relevant updates on diabetes, drugs, Diabscreen Kerala camps, GEMS video etc.

If in case you are not interested in receiving this free monthly newsletter, kindly reply with "delete gems" in the subject line to with a copy to

JDC Diabetes Gems Team
Jothydev's Diabetes and Research Centre, Trivandrum, Kerala, INDIA

Celebrations and Diabetes
Acceptance of Continuing Glucose Monitoring(CGM) as a Routine Investigation in Diabetes

This research presented at Spain, was carried out by a multi disciplinary team led by Dr. Jothydev Kesavadev and included Dr. Arun Shankar, Dr. Pradeep Babu.S.Pilllai, Gopika Krishnan.........


Geographical location and effectiveness of a simple telemedicine program (DTMS®) in diabetes

Another research paper from Jothydev’s Diabetes Research Center presented at ATTD February 2012, Barcelona, Spain discusses the benefits of Diabetes Tele Management System ........


Benefits of "Memory Effect" of better diabetes control on the kidneys after 22 years!!!

The Diabetes Control and Complications Trial was the first large randomized trial in which intensive glycemic control in adolescents and young adults with type 1 diabetes was examined........


Autoantigen Tx Benefits Some Type 1 Diabetics

A phase III European study results show that Autoantigen treatment of new-onset type 1 diabetes was unsuccessful in preserving pancreatic beta-cell function overall; nevertheless the treatment........


Why Coffee lovers are at a Reduced Risk of Type 2 Diabetes

Some previous studies have shown that coffee drinkers are at a lower risk for developing Type 2 diabetes, but the reason was unclear. A new study published in ACS' Journal of Agricultural.........


Diabetes Medicine Updates

Merck succeeded approval  for extended release Janumet........
FDA Rejects Dapagliflozin for Type 2 Diabetes


JDC Updates

Diabscreen Kerala Camp, Chottanikkara ........


   November 2008
   December 2008
   January 2009
   February 2009
  March 2009
  April 2009
  May 2009
  June 2009
  July 2009
  August 2009
  September 2009
  October 2009
  November 2009
  December 2009
  January 2010
  February 2010
  March 2010
  April 2010
  May 2010
  June 2010
  July 2010
  August 2010
  September 2010
  October 2010
  November 2010
  December 2010
  January 2011
  February 2011
  March 2011
  April 2011
  May 2011
  June 2011
  July 2011
   August 2011
   September 2011
   October 2011
   November 2011
   December 2011
   January 2012
Click here to subscribe to JDC Diabetes Gems

QR Code - Click for the newsletter link

The Newsletter team:
 Chief Editor
Dr. Jothydev Kesavadev
 Managing editor Sunitha Jothydev
 Sub Editor Dr. Arun Shankar
 Editor Neethu Annie Simon (Unit head, JDC2, Kochi)
 Scientific Editor Gopikakrishnan G R .(Research Pharmacist, JDC1, Trivandrum)

Website counter Share/Bookmark